Evidence map›Paper›PMID 32022993›Full record

ArticleJournal of diabetes investigation2020

Risk and population attributable fraction of metabolic syndrome and impaired fasting glucose for the incidence of type 2 diabetes mellitus among middle-aged Japanese individuals: Aichi Worker's Cohort Study.

Kayo Kaneko, Hiroshi Yatsuya, Yuanying Li, Mayu Uemura, Chifa Chiang, Yoshihisa Hirakawa, Atsuhiko Ota, Koji Tamakoshi, Atsuko Aoyama

Open access · goldAbstract read
In one paragraph

Article in Journal of diabetes investigation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Uncurtaining the pivotal role of ABC transporters in diabetes mellitus.Environmental science and pollution research international · 2021
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Kayo KanekoDepartment of Public Health and Health Systems, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID https://orcid.org/0000-0002-1580-9748
Hiroshi YatsuyaDepartment of Public Health and Health Systems, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID https://orcid.org/0000-0002-6220-9251
Yuanying LiDepartment of Public Health, Fujita Health University School of Medicine, Toyoake, Japan.ORCID https://orcid.org/0000-0002-4059-6406
Mayu UemuraDepartment of Public Health and Health Systems, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Chifa ChiangDepartment of Public Health and Health Systems, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Yoshihisa HirakawaDepartment of Public Health and Health Systems, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID https://orcid.org/0000-0001-8483-5053
Atsuhiko OtaDepartment of Public Health, Fujita Health University School of Medicine, Toyoake, Japan.ORCID https://orcid.org/0000-0001-6452-1823
Koji TamakoshiDepartment of Nursing, Nagoya University School of Health Sciences, Nagoya, Japan.
Atsuko AoyamaDepartment of Public Health and Health Systems, Nagoya University Graduate School of Medicine, Nagoya, Japan.ORCID https://orcid.org/0000-0003-2717-4919
Nagoya University · JPFujita Health University · JP

Funding

Aichi Health Promotion FoundationJapan Atherosclerosis Prevention FundMEXT/JSPS KAKENHI 13470087MEXT/JSPS KAKENHI 15K08802MEXT/JSPS KAKENHI 16590499MEXT/JSPS KAKENHI 16K19278MEXT/JSPS KAKENHI 17390185MEXT/JSPS KAKENHI 17790384MEXT/JSPS KAKENHI 18590594MEXT/JSPS KAKENHI 18H03057MEXT/JSPS KAKENHI 20590641MEXT/JSPS KAKENHI 22390133MEXT/JSPS KAKENHI 23590787MEXT/JSPS KAKENHI 23659346MEXT/JSPS KAKENHI 25893088MEXT/JSPS KAKENHI 26293153Ministry of Health, Labor and Welfare H26-Junkankitou [Seisaku]-Ippan-001Ministry of Health, Labor and Welfare H29-Junkankitou [Seishuu]-Ippan-003Uehara Memorial Fund
6 · The paper itself

Abstract

AIMS/

introductionThe Japanese government started a nationwide screening program for metabolic syndrome (MetS) to prevent cardiovascular diseases and diabetes in 2008. Although impaired fasting glucose (IFG) is a strong predictor for type 2 diabetes mellitus, the program does not follow up IFG in non-MetS individuals. This study aimed to examine the risk and the population attributable fraction (PAF) of MetS and IFG for incidence of type 2 diabetes mellitus. MATERIALS AND

methodsJapanese workers (3,417 men and 714 women) aged 40-64 years without a history of diabetes were prospectively followed. MetS was defined as either abdominal obesity plus two or more metabolic risk factors, or being overweight in the case of normal waist circumference plus three or more metabolic risk factors. IFG was defined as fasting blood glucose 100-125 mg/dL.

resultsDuring a mean 6.3 years, 240 type 2 diabetes mellitus cases were identified. Compared with those without MetS and IFG, the multivariable-adjusted hazard ratios (95% confidence interval) of non-MetS individuals with IFG, MetS individuals without IFG and MetS individuals with IFG for type 2 diabetes mellitus were 4.9 (3.4-7.1), 2.4 (1.6-3.5) and 8.3 (5.9-11.5), respectively. The corresponding PAFs for type 2 diabetes mellitus incidence were 15.6, 9.1 and 29.7%, respectively.

conclusionsIFG represented a higher risk and PAF than MetS for type 2 diabetes mellitus incidence in middle-aged Japanese individuals. The coexistence of MetS and IFG showed the highest risk and PAF for type 2 diabetes mellitus incidence. The current Japanese MetS screening program should be reconsidered to follow up non-MetS individuals with IFG.

Indexed as

FastingAdultBiomarkersDiabetes Mellitus, Type 2FemaleFollow-Up StudiesGlucose IntoleranceHumansIncidenceJapanMaleMetabolic SyndromeMiddle AgedObesityPrognosisProspective StudiesBiomarkersImpaired fasting glucoseMetabolic syndromePopulation attributable fraction and type 2 diabetes mellitus

Identifiers

PMID32022993
PMCPMC7477517
OpenAlexW3004914386

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.